No one is immune to the effects of the world’s most pressing medical challenges. And none of these challenges are immune to the brilliance and dedication of IMRIC’s researchers. Get to know them a little better by checking out their bios.
Before I became an IMRIC researcher I was interested in animal sciences and began working on marine ecology and fish parasites. By the time I was ready for my post-doctoral work, scientists were starting to experiment with genetic manipulation of the malaria parasite which really interested me. So I moved to NY to work at Cornell Medical School with Kirk Deitsch a leading researcher in genetic manipulation of the malaria pathogen.
What I enjoy about our research at IMRIC is that we work directly on the pathogen. We manipulate it, grow it in blood in the lab and see what the results are. What we do in the IMRIC lab has direct implications for people around the world today.
Like most researchers, I enjoy solving puzzles.
For years, I was curious about the genetics behind diabetes, which led me to look at the beta cells and the genes associated with them. The discovery of the LKB1 gene's role in suppressing insulin development has given my IMRIC research an opportunity to explore whether beta cells can, in fact, be induced to regenerate after injury.
I am excited about the direction in which my research is taking us, and hope the work will pave the way for radical new treatments for diabetes.